Yale Researchers Use CRISPR to Study Genetic Links to Pediatric Developmental Disorders

Yale researchers David Breslow and Mustafa Khokha have developed a CRISPR-based platform to study the connection between specific genes and pediatric developmental disorders. Their work focuses on understanding how genetic variations contribute to these conditions, aiming to shed light on the underlying mechanisms that link cellular functions to disease.

The researchers have collaborated for years, addressing the challenge of identifying and analyzing the role of certain genes in developmental disorders. By utilizing CRISPR technology, they aim to pinpoint genetic factors that influence these diseases, providing a clearer picture of their biological origins. This approach allows for precise gene editing, enabling scientists to observe how changes in specific genes impact cellular behavior and development. The findings could potentially enhance understanding of these complex conditions and inform future research efforts.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: The formatted date is: **December 2, 2025**

Related posts:

Democratic Lawmakers Challenge Health Secretary Kennedy Jr.’s Suspension of Public Comment on Agency Operations Animal-Based Fats Linked to Increased Tumor Growth in Obese Mice Study Finds Primary Care Clinics Integrate Continuous Glucose Monitors to Enhance Diabetes Management Study Introduces Single Artificial Neuron Model for Nutrient-Response Analysis in Biological Systems

Author

GOAI